DUBLIN--(BUSINESS WIRE)--The "Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss" report has been added to ResearchAndMarkets.com's offering.
This Genetic Technology TOE depicts life sciences trends across drug delivery platforms, cancer immunotherapies, biomarker identification, and gene therapy.
Among the therapeutic areas in focus, age-related macular degeneration (AMD), aggressive childhood cancers, and bladder cancer, are of note.
Clinical trial analysis of recombinant drugs for different forms of cancer is also presented.
Key Topics Covered
- Advancements in Mode of Drug Delivery for Age-related Macular Degeneration
- Immunotherapy Developments for Aggressive Childhood Cancers
- Novel Biomarkers for p53-like Subtype of Bladder Cancer
- Novel Gene Therapy Construct that Halts Vision Loss
- Clinical Trial Analysis of Recombinant Drugs for Different Forms of Cancer
- Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/3bvvvg/2018_innovations?w=4
